Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02346916 · ClinicalTrials.gov registry record · NA
Chest Pain Perception and Capsaicin Sensitivity in Patients With Acute Cardiac Ischemia
A NA study, sponsored by Bassett Healthcare.
- Completed
- Registry status
- NA
- Development phase
- 22
- Enrollment target
NCT02346916 is a NA study that has completed, run by Bassett Healthcare. The registered enrollment target is 22 participants.
The verdict
NCT02346916, a NA study, has completed, sponsored by Bassett Healthcare.
- COMPLETED
- Registry status
- NA
- Development phase
- 22 participants
- Enrollment target
Study Summary
The purpose of this study is to determine whether there is a positive correlation between the ability to sense chest pain in the context of myocardial ischemia and the ability to sense discomfort associated with the topical application of the TRPV1 agonist capsaicin (the active ingredient on hot chili peppers).
Interventions
- DRUG Capsaicin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 22 participants |
| Start Date | 2013-10 |
| Est. Completion | 2015-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02346916
The ClinicalTrials.gov registry entry for NCT02346916 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Bassett Healthcare, which has 16 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Capsaicin is the first listed.
NCT02346916 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02346916 about?
NCT02346916 is a clinical study titled "Chest Pain Perception and Capsaicin Sensitivity in Patients With Acute Cardiac Ischemia". The purpose of this study is to determine whether there is a positive correlation between the ability to sense chest pain in the context of myocardial ischemia and the ability to sense discomfort associated with the topical application of the TRPV1 agonist capsaicin (the active ingredient on hot chi...
What is the current status of trial NCT02346916?
This trial is currently completed. It is a NA study. The enrollment target is 22 participants. The study started on 2013-10. Estimated completion is 2015-08.
What interventions are being tested in trial NCT02346916?
The interventions under investigation include: Capsaicin (DRUG).
Who is sponsoring clinical trial NCT02346916?
This trial is sponsored by Bassett Healthcare, which has 16 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.